Walleye Trading’s Cabaletta Bio CABA Stock Holding History

Walleye Trading’s Portfolio CABA Stock Details CABA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-22,905	Closed	-$87K	–	5362
2021 Q4	$87K	Buy	+22,905	New	+$244K	﹤0.01%	4449

Other funds holding CABA

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Walleye Trading's CABA Position: Q1 2022 in Review

Walleye Trading sold out of Cabaletta Bio (CABA) in Q1 2022, closing a stake of 22,905 shares — an estimated $87K sold.

Walleye Trading first reported a position in CABA in Q4 2021 and held it in 1 quarter. The position peaked at $87K in Q4 2021. 62 funds tracked by Wall St. Rank hold CABA as of Q1 2022.

Walleye Trading reported no remaining Cabaletta Bio position as of Q1 2022 after selling out during the quarter.
Walleye Trading sold 22,905 Cabaletta Bio shares in Q1 2022, an estimated $87K.
Walleye Trading first reported a position in Cabaletta Bio in Q4 2021 and held it in 1 quarter.
Walleye Trading's Cabaletta Bio position peaked at $87K in Q4 2021.
62 funds tracked by Wall St. Rank held Cabaletta Bio as of Q1 2022.

Based on Walleye Trading's 13F filing for Q1 2022, filed 16 May 2022.